Dr Habeebullah Life Sciences has informed that the meeting of the Board of Directors of the Company is scheduled on 14/02/2020, to consider and approve Un-audited financial results for the quarter ended 31.12.2019; Limited Review Report for the quarter ended 31.12.2019; and any other business with the permission of the Chair.
The above information is a part of company’s filings submitted to BSE.